ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update Pharmaceutical Investing
Amicus Therapeutics Announces Full-Year 2017 Financial Results and 2018 Corporate Updates Biotech Investing
BeiGene Announces Approval of REVLIMID® for Newly Diagnosed Multiple Myeloma in China Pharmaceutical Investing
Mesoblast Operational Highlights and Financial Results for the Half-Year Ended December 31, 2017 Genetics Investing
Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results Biotech Investing
GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2017 Financial Results Biotech Investing
MacroGenics Provides Update on Corporate Progress and 2017 Financial Results Pharmaceutical Investing
Achaogen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update Pharmaceutical Investing
Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness